Cargando…
Enrichment-triggered Prodrug Activation Demonstrated through Mitochondria-targeted Delivery of Doxorubicin and Carbon Monoxide
Controlled activation is a critical component in prodrug development. Herein we report a concentration-sensitive platform approach for bioorthogonal prodrug activation by taking advantage of reaction kinetics. Using two “click and release” systems, we demonstrate enrichment and prodrug activation sp...
Autores principales: | Zheng, Yueqin, Ji, Xingyue, Yu, Bingchen, Ji, Kaili, Gallo, David, Csizmadia, Eva, Zhu, Mengyuan, Choudhury, Manjusha Roy, De La Cruz, Ladie Kimberly C., Chittavong, Vayou, Pan, Zhixiang, Yuan, Zhengnan, Otterbein, Leo E., Wang, Binghe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235738/ https://www.ncbi.nlm.nih.gov/pubmed/29760413 http://dx.doi.org/10.1038/s41557-018-0055-2 |
Ejemplares similares
-
Hydrogen sulfide prodrugs—a review
por: Zheng, Yueqin, et al.
Publicado: (2015) -
Adapting decarbonylation chemistry for the development of prodrugs capable of in vivo delivery of carbon monoxide utilizing sweeteners as carrier molecules
por: De La Cruz, Ladie Kimberly, et al.
Publicado: (2021) -
Friend or foe? Carbon monoxide and the mitochondria
por: Schallner, Nils, et al.
Publicado: (2015) -
Redox and catalase-like activities of four widely used carbon monoxide releasing molecules (CO-RMs)
por: Yuan, Zhengnan, et al.
Publicado: (2021) -
Organic carbon monoxide prodrug, BW-CO-111, in protection against chemically-induced gastric mucosal damage
por: Bakalarz, Dominik, et al.
Publicado: (2021)